This total event is approved by the NCRA for 6 CE hours, 5 of which meet the criteria for Category A.

Cytoreductive Surgery and HIPEC: Why, When, and How

Jula Veerapong, MD, General and Cytoreductive Surgeon, Professor at UCSD, researcher, author, speaker, Cancer Liason Physician at Moores Cancer Center.

1.0 hr   

Dr. Jula Veerapong

Chronic Lymphocytic Leukemia: A Better Understanding of This Common Disease

Michael Choi, MD, Internist and Hematologist, Professor at UCSD, researcher, author, speaker.

1.0 hr

Dr. Michael Choi

An Evolving Landscape: The Role of Genetics in Cancer Treatment and Prevention

​Lisa Madlensky, PhD, Board-certified genetic counselor, Professor and Director of Family Cancer Genetics Program at UCSD, researcher, author, member NCCN committee on genetic risk assessment guidelines.

1.0 hr

Business Meeting
Ovarian Cancer: Changing the Outlook for Patients
Ramez Eskander, MD, Gynecologic Oncologist and Surgeon at UCSD, researcher novel therapeutics.
A Team Approach to Rectal Cancer, and Post Treatment Stages
Nicole Lopez, MD, Colorectal Surgeon, Professor at UCSD, researcher, author, founder of Moores NAPRC accredited Rectal Cancer Program, mentor.
Bladder Cancer – What Path to Take?
Karim Kader, MD, Urologist,  Professor and Director of Urologic Oncology at UCSD,  researcher, speaker, author, Chairman of Moores Cancer Center Cancer Committee.

Pin It on Pinterest

Share This